Liver transplantation; cancer transmission; cancer
Abstract :
[en] Transmission of undiagnosed malignancy with the graft is a dramatic complication of liver transplantation. Alternatives in the management of the recipients of livers, harvested from donors with malignancy diagnosed shortly after transplantation, are either early re-transplantation or close follow-up without re-operation. We reported 4 cases of liver recipients whose allografts were harvested from donors who were diagnosed with malignancy shortly after the liver transplantation. One recipient underwent re-transplantation, and the three other allografts were not removed. No recipient developed recurrence in the follow-up. While graft removal may be the only way to avoid tumor recurrence in recipients of liver graft harvested from donor with malignancy, close follow-up without re-operation may also be considered. The risk of tumor transferral may depend on the histopathological aggressiveness and metastatic potential of the donor tumor, and may be low for low-grade, local tumors. This risk should be evaluated by analyzing large series, using databases of Eurotransplant or United Network for Organ Sharing.
Disciplines :
Oncology Gastroenterology & hepatology Surgery
Author, co-author :
Detry, Olivier ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation
Honore, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation
Jacquet, Nicolas
Meurisse, Michel ; Université de Liège - ULiège > Département des sciences cliniques > Chirurgicale abdominale
Language :
English
Title :
Management of Recipients of Hepatic Allografts Harvested from Donors with Malignancy Diagnosed Shortly after Transplantation
DETRY O, DETROZ B, D'SILVA M et al. Misdiagnosed malignancy in transplanted organs. Transplant Int 1993: 6: 50.
PENN I. Malignancy in transplanted organs. Transplant Int 1993: 6. 1.
PENN I. Neoplasia: an example of plasticity of the immune response. Transplant Proc 1996: 28: 2089.
COLQUHOUN SD, ROBERT ME, SHAKED A et al. Transmission of CNS malignancy by organ transplantation. Transplantation 1994: 57: 970.
DETRY O. HONORÉ P, MEURTSSE M, BONNET P, JACQUET N. Malignancy transplantation with graft: do the patients with primary central nervous system tumor have to be excluded from the donor pool? Transplant Int 1997: 10: 83.
DETRY O, BONNET P, HONORé P, MEURTSSE M, JACQUET N. What is the risk of the transferral of an undetected neoplasm during organ transplantation? Transplant Proc 1997: 29: 2410.
PENN I. Transmission of cancer from organ donors. Nephrologia 1995: 15: 205.
LOH E, COUCH FJ, HENDRICKSEN C et al. Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation. J Am Med Assoc 1997: 277: 133.
MOTZER RJ, BANDER NH, NANUS DM. Renal-cell carcinoma. New Engl J Med 1996: 335: 865.